Lys600
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.4
Powered by Cell Signaling Technology
Home > Acetylation Site Page: > Lys600  -  DDX21 (human)

Site Information
HFkQsAEkLIEEKGA   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 36296739

In vivo Characterization
Methods used to characterize site in vivo:
modification-specific antibody ( 1 ) , western blotting ( 1 )
Disease tissue studied:
breast cancer ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Treatments:
nicotinamide ( 1 )

Downstream Regulation
Effects of modification on DDX21:
enzymatic activity, inhibited ( 1 )
Effects of modification on biological processes:
transcription, inhibited ( 1 )

References 

1

Song C, Hotz-Wagenblatt A, Voit R, Grummt I (2017) SIRT7 and the DEAD-box helicase DDX21 cooperate to resolve genomic R loops and safeguard genome stability. Genes Dev
28790157   Curated Info